Latest Travel News

Lark Distilling Co. reported a robust Q3FY25 with net sales rising 31% to $4.3 million, driven by growth in travel retail, ecommerce, and exclusive whisky releases. The company also progressed its Pontville distillery redevelopment and maintained positive operating cash flow.

Entertainment Rewards Ltd reports its strongest Q3 revenue in three years, driven by growth in Frequent Values and Paid Advertising, alongside a significant debt restructuring that reclassifies $22.5 million as equity.

My Rewards International has completed its acquisition of Fly Wallet and strengthened its financial position with a $15 million put option facility, while working to lift its ASX trading suspension.

My Rewards International Limited has completed its acquisition of Fly Wallet, a Mastercard principal member specialising in white label loyalty wallet solutions, in a $785,000 deal combining shares and cash installments.

Corporate Travel Management Limited reported strong half-year results for the period ending December 31, 2024, with significant EBITDA growth and effective capital management, returning $52.3 million to shareholders. The company sets ambitious FY25 and FY26 targets focused on sustainable profit growth and market share expansion.

Corporate Travel Management delivered robust first-half results led by ANZ and North America, while previewing ambitious FY26 targets to double EPS within five years.

Corporate Travel Management Limited has announced an unfranked dividend of AUD 0.10 per share for the six months ending December 31, 2024, payable on April 4, 2025.

Corporate Travel Management Limited (CTM) reported a 42% drop in net profit for the half-year ended December 2024, amid a 6% revenue decline. Despite this, strong performances in North America and Australia & New Zealand, alongside ongoing automation and new client wins, position CTM for a rebound in the second half.

Audinate Group Limited's half-year results reveal a sharp 38.4% revenue decline and a $2.2 million net loss, driven by reduced chip demand as customers clear inventory. Yet, growth in OEM partnerships hints at potential recovery.

Micro-X Ltd has secured a $6 million contract extension from the U.S. Department of Homeland Security to develop and test additional self-screening airport security checkpoints, marking a significant step forward in its innovative security technology program.

Island Pharmaceuticals has successfully completed patient dosing in the Phase 2b therapeutic arm of its PROTECT clinical trial for ISLA-101, targeting dengue fever treatment. High-level results are expected within two months, potentially advancing a significant antiviral candidate.

Burgundy Diamond Mines showcased its vertically integrated diamond business and Ekati mine acquisition at the Bell Potter Unearthed Natural Resources Conference, outlining a robust 2025 operational and financial outlook despite market headwinds.